Taking DNA to market and regulatory default

Journal of Medical Humanities 3 (2):112-127 (1981)
  Copy   BIBTEX

Abstract

The public debate on recombinant DNA research has ended even though significant issues of public interest remain undecided or untouched. The reason for the termination of other than muted public discussion is not simply the removal of an initial fear of catastrophic biohazards. With the cessation of public debate over such hazards came also the dissolution of most public forums. The ends to which recombinant DNA research and development ought to be directed are not matters of public debate. With the transfer of basic research knowledge to the private sector, that sector's proprietary interests and ownership prerogatives effectively deny any continued public participation in charting the future of genesplicing technology and its application.

Other Versions

No versions found

Links

PhilArchive

    This entry is not archived by us. If you are the author and have permission from the publisher, we recommend that you archive it. Many publishers automatically grant permission to authors to archive pre-prints. By uploading a copy of your work, you will enable us to better index it, making it easier to find.

    Upload a copy of this work     Papers currently archived: 104,467

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Analytics

Added to PP
2010-08-24

Downloads
49 (#492,195)

6 months
14 (#228,455)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

2 Life is Patently Not Human‐Made.Key Dismukes - 1980 - Hastings Center Report 10 (5):11-12.

Add more references